| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_065fe7c4146d471ac47823ff7c1d911f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2014-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c615896e77019b9d9ced305cf0b3ab5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2e9c77f9840f8f1bd700a18779746fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6739f0692e85b769c53d48942a9f0f04 |
| publicationDate |
2014-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201442741-A |
| titleOfInvention |
Oral administration of shady taste of shaded silodosin |
| abstract |
The present invention provides a novel oral administration preparation which can make a sirolimus which is a very bitter-taste agent have no foreign body sensation, can be taken even if it is anhydrous, and has reproducible urination accompanying prostate hypertrophy. The dissolution of blood in the treatment of an obstacle or the like is effective. The present invention relates to a masking particle and a novel oral administration preparation containing the same, which is a granulated drug particle containing a micro powder of sirolimus by a coating agent containing a non-enteric polymer. Or the coating is obtained, and the content of the non-enteric polymer is 80 parts by mass to 400 parts by mass based on 100 parts by mass of the sirolimus. |
| priorityDate |
2013-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |